↓ Cooling
Health
Experimental vaccine shows promise against deadly brain cancer in some patients
A Phase 2b trial for the SurVaxM brain cancer vaccine shows longer survival for some patients despite missing key study goals.
1 trends tracked about this subject — the full history, oldest to newest below.
A Phase 2b trial for the SurVaxM brain cancer vaccine shows longer survival for some patients despite missing key study goals.